An announcement from Anbio Biotechnology Class A ( ($NNNN) ) is now available. On December 30, 2025, Anbio Biotechnology reported unaudited ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

A sweeping compliance audit by comptroller and auditor general (CAG) of India has exposed serious financial irregularities, ...

US biotech Ultragenyx Pharmaceutical saw its shares tumble over 43% to $19.41 yesterday, after it announced results from the ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

Where do the well-known cannabis compounds THC, CBD and CBC come from? Researchers at Wageningen University & Research have experimentally ...

Aldeyra ’s Reproxalap is the core catalyst. The FDA will make its decision on this asset by March 16, 2026, after a ...

Dietary changes cannot reverse genetically programmed greying, but they can significantly slow progression and improve hair ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Advanced Biomed Inc. (Nasdaq: ADVB) (the 'Company”, 'Advanced Biomed”), a biotechnology company focused on developing and ...

An FDA decision will extend the timeline for possible approval of Inovio's lead new drug candidate, a therapy that could ...

Amgen Inc. (NASDAQ:AMGN) has outperformed the broader market this year, supported by strong financial results and steady ...